JUVENILE XANTHOGRANULOMA
Clinical trials for JUVENILE XANTHOGRANULOMA explained in plain language.
Never miss a new study
Get alerted when new JUVENILE XANTHOGRANULOMA trials appear
Sign up with your email to follow new studies for JUVENILE XANTHOGRANULOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug cobimetinib tested for rare immune cell cancers
Disease control Recruiting nowThis phase 2 study tests the drug cobimetinib in children and adults with Langerhans cell histiocytosis and related disorders that have come back or not responded to standard treatment. Cobimetinib blocks a growth signal that goes haywire in these diseases. The study will enroll …
Matched conditions: JUVENILE XANTHOGRANULOMA
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Caregiver survey aims to uncover hidden struggles in rare disease
Knowledge-focused Recruiting nowThis study surveys 250 informal caregivers (family or friends) of people with Erdheim-Chester disease and similar conditions. Participants complete online questionnaires about their supportive care needs, mood, and sense of purpose. The goal is to identify what caregivers need mo…
Matched conditions: JUVENILE XANTHOGRANULOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:23 UTC